MedPath

METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP

METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP

Discontinued
DIN Number

02245400

Drug Class

Human

Market Date

Mar 28, 2003

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02245400
AIG Number0106292002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
H02AB04 METHYLPREDNISOLONE
Product Specifications
Dosage FormSuspension
Route of AdministrationSoft Tissue Injection ,  Intra-Articular ,  Intramuscular ,  Intrasynovial
AHFS Classification68:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

METHYLPREDNISOLONE ACETATEActive
Strength: 40 MG / ML
Monograph: METHYLPREDNISOLONE ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.